Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors (Q44490788)

3 December 2017

Higher stromal expression of transforming growth factor-beta type II receptors is associated with poorer prognosis breast tumors (English)

1 reference

3 December 2017

3

Donald Weaver

1 reference

3 December 2017

John Barlow

1

1 reference

3 December 2017

David Yandell

series ordinal

2

1 reference

3 December 2017

Theresa Casey

series ordinal

4

1 reference

3 December 2017

Karen Plaut

series ordinal

5

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Breast Cancer Research and Treatment

3 December 2017

1 reference

3 December 2017

79

1 reference

3 December 2017

2

1 reference

3 December 2017

149-159

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1023918026437

3 December 2017

0 references

cites work

A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Mutation analysis of the transforming growth factor beta type II receptor in sporadic human cancers of the pancreas, liver, and breast.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Mutation and downregulation of the transforming growth factor beta type II receptor gene in primary squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Characterization of the promoter region of the human transforming growth factor-beta type II receptor gene.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

How sensitive is PCR-SSCP?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Association between the T29-->C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Serum levels of transforming growth factor beta1 in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Invasion and metastasis of a mammary tumor involves TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

TGFbeta signaling in growth control, cancer, and heritable disorders

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1023918026437

7 January 2021

Identifiers

DOI

10.1023/A:1023918026437

1 reference

Dimensions Publication ID

3 December 2017

0 references

1 reference